
iRhythm Technologies (IRTC) Stock Forecast & Price Target
iRhythm Technologies (IRTC) Analyst Ratings
Bulls say
iRhythm Technologies Inc. is experiencing a positive outlook attributed to an increase in revenue expectations and a rise in the mean comparable group multiples. The company's advancements in ambulatory cardiac monitoring services, particularly through its proprietary Zio System, demonstrate strong volume and pricing trends in its business. The optimistic updates in financial projections reflect the company's effective integration of innovative technology in diagnosing arrhythmias, signaling a robust growth potential in the digital healthcare market.
Bears say
iRhythm Technologies faces significant challenges due to a highly competitive market for ambulatory cardiac monitoring solutions, where competitors may develop more effective products that could diminish iRhythm's market share and commercial opportunities. Additionally, the company's reliance on favorable reimbursement policies from public and private payors introduces financial uncertainty, as changes in coverage or reimbursement rates could adversely impact the adoption and profitability of its Zio service. Compounding these issues, iRhythm has a history of net losses, indicating ongoing financial struggles that suggest concerns regarding its long-term viability in the current healthcare landscape.
This aggregate rating is based on analysts' research of iRhythm Technologies and is not a guaranteed prediction by Public.com or investment advice.
iRhythm Technologies (IRTC) Analyst Forecast & Price Prediction
Start investing in iRhythm Technologies (IRTC)
Order type
Buy in
Order amount
Est. shares
0 shares